The ultrastructure of human livers after prolonged lidoflazine therapy.
D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy / Q000473:pathology; D002462:Cell Membrane / Q000648:ultrastructure; D003594:Cytoplasmic Granules / Q000648:ultrastructure; D005260:Female; D006801:Humans; D007728:Kupffer Cells / Q000648:ultrastructure; D008013:Lidoflazine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D050356:Lipid Metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure*; D008830:Microbodies / Q000648:ultrastructure; D008875:Middle Aged; D008930:Mitochondria, Liver / Q000648:ultrastructure; D010879:Piperazines / Q000627:therapeutic use*; D013997:Time Factors
D010879:Piperazines; D008013:Lidoflazine